Similar articles for PMID: 25416633

Year	Number of Results
2002	1
2009	1
2010	2
2011	5
2012	12
2013	14
2014	23
2015	22
2016	20
2017	12
2018	13
2019	9
2020	11
2021	8
2022	6
2024	0

1

Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer.

Hofheinz F, Lougovski A, Zöphel K, Hentschel M, Steffen IG, Apostolova I, Wedel F, Buchert R, Baumann M, Brenner W, Kotzerke J, van den Hoff J. Hofheinz F, et al. Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):429-37. doi: 10.1007/s00259-014-2953-x. Epub 2014 Nov 22. Eur J Nucl Med Mol Imaging. 2015. PMID: 25416633

2

Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancer.

Apostolova I, Steffen IG, Wedel F, Lougovski A, Marnitz S, Derlin T, Amthauer H, Buchert R, Hofheinz F, Brenner W. Apostolova I, et al. Eur Radiol. 2014 Sep;24(9):2077-87. doi: 10.1007/s00330-014-3269-8. Epub 2014 Jun 26. Eur Radiol. 2014. PMID: 24965509

3

Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer.

Hoshikawa H, Mori T, Yamamoto Y, Kishino T, Fukumura T, Samukawa Y, Mori N, Nishiyama Y. Hoshikawa H, et al. Clin Nucl Med. 2015 Jun;40(6):464-8. doi: 10.1097/RLU.0000000000000652. Clin Nucl Med. 2015. PMID: 25546204

4

Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC.

Apostolova I, Rogasch J, Buchert R, Wertzel H, Achenbach HJ, Schreiber J, Riedel S, Furth C, Lougovski A, Schramm G, Hofheinz F, Amthauer H, Steffen IG. Apostolova I, et al. BMC Cancer. 2014 Dec 1;14:896. doi: 10.1186/1471-2407-14-896. BMC Cancer. 2014. PMID: 25444154 Free PMC article.

5

Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.

Hofheinz F, Li Y, Steffen IG, Lin Q, Lili C, Hua W, van den Hoff J, Zschaeck S. Hofheinz F, et al. Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1485-1494. doi: 10.1007/s00259-019-04307-6. Epub 2019 Apr 4. Eur J Nucl Med Mol Imaging. 2019. PMID: 30949816

6

Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.

Zschaeck S, Li Y, Lin Q, Beck M, Amthauer H, Bauersachs L, Hajiyianni M, Rogasch J, Ehrhardt VH, Kalinauskaite G, Weingärtner J, Hartmann V, van den Hoff J, Budach V, Stromberger C, Hofheinz F. Zschaeck S, et al. PLoS One. 2020 Jul 30;15(7):e0236841. doi: 10.1371/journal.pone.0236841. eCollection 2020. PLoS One. 2020. PMID: 32730364 Free PMC article.

7

Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.

Koyasu S, Nakamoto Y, Kikuchi M, Suzuki K, Hayashida K, Itoh K, Togashi K. Koyasu S, et al. AJR Am J Roentgenol. 2014 Apr;202(4):851-8. doi: 10.2214/AJR.13.11013. AJR Am J Roentgenol. 2014. PMID: 24660716

8

Prognostic role of metabolic parameters of (18)F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma.

Min M, Lin P, Lee MT, Shon IH, Lin M, Forstner D, Bray V, Chicco A, Tieu MT, Fowler A. Min M, et al. Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):1984-94. doi: 10.1007/s00259-015-3104-8. Epub 2015 Jun 17. Eur J Nucl Med Mol Imaging. 2015. PMID: 26081941 Free PMC article.

9

Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.

Lin P, Min M, Lee M, Holloway L, Forstner D, Bray V, Fowler A. Lin P, et al. Eur J Nucl Med Mol Imaging. 2017 May;44(5):801-811. doi: 10.1007/s00259-016-3584-1. Epub 2016 Dec 21. Eur J Nucl Med Mol Imaging. 2017. PMID: 28004135

10

18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.

Lim R, Eaton A, Lee NY, Setton J, Ohri N, Rao S, Wong R, Fury M, Schöder H. Lim R, et al. J Nucl Med. 2012 Oct;53(10):1506-13. doi: 10.2967/jnumed.111.101402. Epub 2012 Aug 14. J Nucl Med. 2012. PMID: 22895812 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

127 results

Results by year